The government of Britain has secured around two million doses of Moderna Inc's Covid-19 vaccine candidate. The vaccine is to be available in Europe as early as the spring also secured around 5 million doses from the U.S. company two weeks ago.
After Prime Minister Nadhim Zahawi, a junior business minister, has taken the responsibility for the deployment of Covid-19 vaccines. Britain now got access to enough doses of Moderna's vaccine candidate for around 3.5 million people. Health minister Matt Hancock made a statement. "With a wide range of vaccine candidates in our portfolio, we stand ready to deploy a vaccine should they receive approval from our medicines regulator, starting with those who will benefit most." Interim data is reported from the last-stage trail of Moderna's experimental vaccine is 94.5% effective in preventing Covid-19. The deliveries of the vaccine to Britain could begin as early as the spring if the vaccine meets the standards of the Medicines and Healthcare products Regulatory Agency.
The Financial Times said that the UK regulator is set to approve the BioNTech-Pfizer vaccine by this week, and deliveries will begin within hours of the authorization. Britain also has secured 100 million doses of the vaccine developed by AstraZeneca PLC and Oxford University and has targeted a rollout to begin before Christmas.
Also Read:-
Demonstrators clash with French policemen over new security law
